The DOI matches its Crossref record; 290 of the 290 references it cites were found in a registry or an index.
Lipoprotein(a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
Open accessAbstract
Scanu, and colleagues cloned and sequenced the LPA gene coding for apo(a) (4, 5), a protein with homology to plasminogen, which accounts for the difference between an Lp(a) particle and an LDL particle.These observations generated a huge scientific interest in Lp(a), leading to an exponential growth in the number of articles published, which then later declined again.Renewed interested in Lp(a) came in 2009 from Pia Kamstrup et al. ( 6) with genetic evidence from Mendelian randomization that high Lp(a) is causally associated with cardiovascular disease, from the Emerging Risk Factors Collaboration led by John Danesh that Lp(a) epidemiologically is continuously and independently associated with cardiovascular disease risk (7), and from Robert Clarke et al. (8) that of 2,100 candidate genes for cardiovascular disease, genetic variation in the LPA gene was the strongest genetic cardiovascular risk factor.Following the publication of these studies, high concentrations of Lp(a) have been considered to be a direct cause of cardiovascular disease, just like high LDL cholesterol concentrations.Genetic evidence largely free of confounding and fully free of reverse causation, two major problems of observational epidemiology, is what has cemented the understanding of causality of Lp(a) for cardiovascular disease.These novel and important findings led the European Atherosclerosis Society to publish a 2010 consensus panel statement recommending screening for elevated Lp(a) in individuals at intermediate, high, or very high cardiovascular risk, and suggested a desirable plasma concentration of less than 50 mg/dl (9).Of note, we naturally were fully aware that the risk of cardiovascular disease increases already at Lp(a) levels above 30 mg/dl, but to get the attention of the clinical community, we believed it was the best strategy to start focusing on individuals with the highest cardiovascular risk, that is, the 20% of individuals with concentrations above 50 mg/dl.Abstract Human epidemiologic and genetic evidence using the Mendelian randomization approach in large-scale studies now strongly supports that elevated lipoprotein (a) [Lp(a)] is a causal risk factor for cardiovascular disease, that is, for myocardial infarction, atherosclerotic stenosis, and aortic valve stenosis.The Mendelian randomization approach used to infer causality is generally not affected by confounding and reverse causation, the major problems of observational epidemiology.This approach is particularly valuable to study causality of Lp(a), as single genetic variants exist that explain 27-28% of all variation in plasma Lp(a).The most important genetic variant likely is the kringle IV type 2 (KIV-2) copy number variant, as the apo(a) product of this variant influences fibrinolysis and thereby thrombosis, as opposed to the Lp(a) particle per se.We speculate that the physiological role of KIV-2 in Lp(a) could be through wound healing during childbirth, infections, and injury, a role that, in addition, could lead to more blood clots promoting stenosis of arteries and the aortic valve, and myocardial infarction.Randomized placebo-controlled trials of Lp(a) reduction in individuals with very high concentrations to reduce cardiovascular disease are awaited.Recent genetic evidence documents elevated Lp(a) as a cause of myocardial infarction, atherosclerotic stenosis, and aortic valve stenosis.-Nordestgaard,B. G., and A. Langsted.Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elevated baseline and on-statin treatment Lp(a) concentration above the 80th percentile of the general population (50 mg/dL) is a strong genetic risk factor for cardiovascular disease independent of LDLC [23,24].”
From Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM (2020) · cites this paper as [23]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, several randomized trials have shown that directly infused HDL mimetics increase plasma HDL-C concentrations, but do not reduce the progression of atherosclerosis as measured by intravascular ultrasound [68,69].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [69]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–290 of 290
The genetics of the Lp antigen
Schultz, J. S., Shreffler, D. C., Sing, C. F., et al. (1974) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1974.tb01991.x · Cited by 60
Immunolocalization of Lipoprotein(a) in Wounded Tissues
Yano, Y., Shimokawa, K., Okada, Y., & Noma, A. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500408 · Cited by 58
Apolipoprotein (a) alleles determine lipoprotein (a) particle density and concentration in plasma.
Kraft, H. G., Sandholzer, C., Menzel, H.-J., & Utermann, G. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.3.302 · Cited by 57
Geethanjali, F. S., Luthra, K., Lingenhel, A., Kanagasabapathy, A. S., Jacob, J., Srivastava, L. M., Vasisht, S., Kraft, H.-G., & Utermann, G. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00143-6 · Cited by 57
Partial characterization of lipoproteins containing apo[a] in human atherosclerotic lesions
Hf, H., O'Neil, J. C., & Yashiro, A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39699-1 · Cited by 57
Brazier, L., Tiret, L., Luc, G., Arveiler, D., Ruidavets, J. B., Evans, A., Chapman, J., Cambien, F., & Thillet, J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00333-5 · Cited by 56
Lipoprotein(a) and its role in atherothrombotic disease.
Gc, H., & Sv, P. (1993) · PubMed · Cited by 55
Cooke, T., Sheahan, R. G., Foley, D. P., et al. (1994) · Circulation · doi:10.1161/01.cir.89.4.1593 · Cited by 54
Kark, J. D., Sandholzer, C., Friedlander, Y., & Utermann, G. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90124-d · Cited by 54
Langsted, A., Varbo, A., Kamstrup, P. R., & Nordestgaard, B. G. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1096 · Cited by 54
Self-citationRonald, J., Rajagopalan, R., Cerrato, F. E., Nord, A. S., Hatsukami, T. S., Kohler, T. R., Marcovina, S. M., Heagerty, P. J., & Jarvik, G. P. (2010) · Stroke · doi:10.1161/strokeaha.110.591230 · Cited by 52
Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population
Lim, E. T., Würtz, P., Havulinna, A. S., Palta, P., Tukiainen, T., Rehnström, K., Esko, T., Mägi, R., Inouye, M., Lappalainen, T., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004494 · Cited by 49
Kosch, A., Junker, R., Kurnik, K., et al. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00287-5 · Cited by 49
Nielsen, L. B., Stender, S., Jauhiainen, M., & Nordestgaard, B. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118824 · Cited by 48
Self-citationSINKING PRE-BETA LIPOPROTEIN AND CORONARY HEART DISEASE IN JAPANESE-AMERICAN MEN IN HAWAII
Rhoads, G. G., Morton, N. E., Gulbrandsen, C. L., et al. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112631 · Cited by 48
Three alleles for quantitative Lp(a)
Hasstedt, S. J., & Williams, R. R. (1986) · Genetic Epidemiology · doi:10.1002/gepi.1370030106 · Cited by 47
Lipoprotein (a): A Risk Factor for Peripheral Vascular Disease
Widmann, M. D., & Sumpio, B. E. (1993) · Annals of Vascular Surgery · doi:10.1007/bf02002128 · Cited by 47
Danik, J. S., Buring, J. E., Chasman, D. I., Zee, R. Y. L., Ridker, P. M., & Glynn, R. J. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12056 · Cited by 46
Nielsen, L. B., Juul, K., & Nordestgaard, B. G. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.4.641 · Cited by 46
Self-citationYeang, C., Cotter, B. R., & Tsimikas, S. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6634-1 · Cited by 46
Kreuzer, J., Lloyd, M. B., Bok, D., Fless, G. M., Scanu, A. M., Lusis, A. J., & Haberland, M. E. (1994) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(94)90137-6 · Cited by 45
Bowden, J.-F., Pritchard, P. H., Hill, J. S., et al. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1561 · Cited by 45
Abe, A., Noma, A., Lee, Y. J., et al. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90033-d · Cited by 44
Effects of serum levels of novel atherosclerotic risk factors on aortic valve calcification.
Bozbaş, H., Yı́ldı́rı́r, A., Atar, İ., Pirat, B., Eroğlu, S., Aydınalp, A., Özin, B., & Müderrisoğlu, H. (2007) · PubMed · Cited by 43
Lingenhel, A., Kraft, H. G., Kotze, M., Peeters, A. V., Kronenberg, F., Kruse, R., & Utermann, G. (1998) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200152 · Cited by 43
The behaviour of Lipoprotein(a) in patients with various diseases
van Wersch, J. W. J. (1994) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519409088568 · Cited by 42
Gambhir, J. K., Kaur, H., Prabhu, K. M., Morrisett, J. D., & Gambhir, D. S. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.01.016 · Cited by 41
Orho‐Melander, M. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12407 · Cited by 41
Lipoprotein(a) in diet-induced atherosclerosis in nonhuman primates.
Nachman, R. L., Gavish, D., Azrolan, N., & Clarkson, T. B. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.32 · Cited by 40
Bos, S., Duvekot, M. H. C., Blommesteijn-Touw, A. C., Verhoeven, A. J. M., Mulder, M. T., Watts, G. F., Sijbrands, E. J. G., & van Lennep, J. E. R. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.024 · Cited by 39
Transfer of Lipoprotein(a) and LDL Into Aortic Intima in Normal and in Cholesterol-Fed Rabbits
Nielsen, L. B., Nordestgaard, B. G., Stender, S., Niendorf, A., & Kjeldsen, K. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1492 · Cited by 38
Self-citationReblin, T., Meyer, N., Labeur, C., Henne‐Bruns, D., & Beisiegel†, U. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05445-o · Cited by 37
Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism
Sticchi, E., Magi, A., Kamstrup, P. R., Marcucci, R., Prisco, D., Martinelli, I., Mannucci, P. M., Abbate, R., & Giusti, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149427 · Cited by 36
Dahlén, Weinehall, Weinehall, Stenlund, Jansson, Hallmans, Huhtasaari, & Wall (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00422.x · Cited by 35
Tybjærg‐Hansen, A., Jensen, H. K., Benn, M., Steffensen, R., Jensen, G. B., & Nordestgaard, B. G. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000149380.94984.f0 · Cited by 35
Self-citationABrown, S., DMorrisett, J., EBoerwinkle, RHutchinson, & WPatsch (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · Cited by 35
Grebe, M. T., Schoene, E., Schaefer, C. A., Boedeker, R. H., Kemkes‐Matthes, B., Voß, R., & Tillmanns, H. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.01.017 · Cited by 34
Guo, H.-C., Chapman, J., Bruckert, É., Farriaux, J. P., & de Gennes, J.-L. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90100-h · Cited by 34
Lipoprotein (a) in patients with spontaneous venous thromboembolism
Vormittag, R., Vukovich, T., Stain, M., Lehr, S., Minar, E., & Pabinger, I. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.03.002 · Cited by 34
Leitersdorf, E., Friedlander, Y., Bard, J., Fruchart, J., Eisenberg, S., & Stein, Y. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41918-2 · Cited by 34
Ghiselli, G., Gaddi, A. V., Barozzi, G., Ciarrocchi, A., & Descovich, G. (1992) · Metabolism · doi:10.1016/0026-0495(92)90163-5 · Cited by 33
Gazzaruso, C., Garzaniti, A., Falcone, C., et al. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00536.x · Cited by 32
Role of genetic prothrombotic risk factors in childhood caval vein thrombosis
Münchow, N., Kosch, A., Schobeß, R., et al. (1999) · European Journal of Pediatrics · doi:10.1007/pl00014334 · Cited by 31
Carmena, R., Lussier-Cacan, S., Roy, M., Minnich, A., Lingenhel, A., Kronenberg, F., & Davignon, J. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.1.129 · Cited by 31
Parlavecchia, M., Pancaldi, A., Taramelli, R., et al. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90401-4 · Cited by 31
López, S., Buil, A., Ordóñez‐Llanos, J., Souto, J. C., Almasy, L. A., Lathrop, M. G., Blangero, J., Blanco‐Vaca, F., Fontcuberta, J., & Soria, J. M. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.114 · Cited by 31
Pedro‐Botet, J., Sentı́, M., Auguet, T., et al. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90179-x · Cited by 30
Hojo, Y., Kumakura, H., Kanai, H., Iwasaki, T., Ichikawa, S., & Kurabayashi, M. (2016) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jev338 · Cited by 30
Keesler, G. A., Li, Y., Skiba, P. J., Fless, G. M., & Tabas, I. A. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.8.1337 · Cited by 28
Inverse association between serum lipoprotein(a) and cerebral hemorrhage in the Japanese population
Ishikawa, S., Kotani, K., Kario, K., Kayaba, K., Gotoh, T., Nakamura, Y., & Kajii, E. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.11.032 · Cited by 27
Genetics of the Gc Serum Types: Associations and Linkage Relations
Mohr, J., & Reinskou, T. (1963) · Human Heredity · doi:10.1159/000151815 · Cited by 27
Complex segregation analysis of the Lp(a)/pre‐ß1‐lipoprotein trait
Iselius, L., Dahlén, G., de Faire, U., & Lundman, T. (1981) · Clinical Genetics · doi:10.1111/j.1399-0004.1981.tb01820.x · Cited by 27
Zabaneh, D., Meena Kumari, B., Sandhu, M. S., Wareham, N. J., Wainwright, N. W. J., Papamarkou, T., Hopewell, J. C., Clarke, R., Li, K., Palmen, J., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.015 · Cited by 27
Lipoprotein (a): Coming of Age at Last
Witztum, J. L., & Ginsberg, H. N. (2016) · Journal of Lipid Research · doi:10.1194/jlr.e066985 · Cited by 27
Fless, G. M., & Snyder, M. L. (1994) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(94)90125-2 · Cited by 25
Kalina, Á., Császár, A., Füst, G., Nagy, B., Szalai, C., Karádi, I., Duba, J., Prohászka, Z., Horváth, L., & Dieplinger, H. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00500-9 · Cited by 25
Katsouras, C. S., Karabina, S., Tambaki, A. P., Goudevenos, J. A., Michalis, L. K., Tsironis, L. D., Stroumbis, C., Elisaf, M., Sideris, D. A., & Tselepis, A. D. (2001) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670100800511 · Cited by 25
Šrámek, A., Reiber, J. H. C., Baak-Pablo, R. F., Sturk, A., & Rosendaal, F. R. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00064.x · Cited by 24
The mysterious lipoprotein(a) is still good for a surprise
Lamina, C., & Kronenberg, F. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70085-8 · Cited by 22
Zorio, E., Falcó, C., Arnau, M. Á., España, F., Osa, A., Ramón, L., Castelló, R., Almenar, L., Palencia, M. A., & Estellés, A. (2006) · PubMed · Cited by 22
Lipoprotein (a) as a risk factor for atherosclerotic diseases.
Dahlén, G. (1988) · PubMed · Cited by 22
Genetics of the Lp Serum Types: Associations and Linkage Relations
Mohr, J., & Berg, K. (1963) · Human Heredity · doi:10.1159/000151817 · Cited by 22
Calmarza, P., Trejo, J., Lapresta, C., & López, P. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711423216 · Cited by 20
Barlera, S., Specchia, C., Farrall, M., Chiodini, B., Franzosi, M. G., Rust, S., Green, F. R., Nicolis, E., Peden, J. F., Assmann, G., et al. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201732 · Cited by 19
Zeljković, A., Bogavac‐Stanojević, N., Jelić‐Ivanović, Z., Spasojević‐Kalimanovska, V., Vekić, J., & Spasić, S. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2008.10.010 · Cited by 19
Lp(a) lipoprotein in patients with arterial insufficiency of the lower extremities
Norrgård, Ö., Ängquist, K., & Dahlén, G. H. (1991) · European Journal of Vascular Surgery · doi:10.1016/s0950-821x(05)80510-9 · Cited by 18
Gazzaruso, C., Garzaniti, A., Buscaglia, P., et al. (1998) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679800500105 · Cited by 18
How Does Elevated Lipoprotein(a) Cause Aortic Valve Stenosis? ∗
Nordestgaard, B. G., & Langsted, A. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.045 · Cited by 18
Self-citationIncreased Lipoprotein(a) levels are not a steady prothrombotic defect
Korte, W. C., Greiner, J., Feldges, A., et al. (2001) · Blood · doi:10.1182/blood.v98.6.1993 · Cited by 17
Heterogeneity of lipoprotein Lp(a) and apolipoprotein(a).
Grinstead, G. F., & Ellefson, R. D. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.6.1036 · Cited by 16
Lipoprotein (a) phenotypes in south Indian patients with coronary artery disease.
Geethanjali, F. S., Jose, V. J., & Kanagasabapathy, A. S. (2002) · PubMed · Cited by 16
Simó, J. M., Vilella, E., Ribas, M., et al. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615598 · Cited by 15
Emanuele, E., Peros, E., Minoretti, P., D’Angelo, A., Montagna, L., Falcone, C., & Geroldi, D. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.07.023 · Cited by 15
Martín, S., Pedro‐Botet, J., Joven, J., Simó, J. M., Ladona, M. G., Pavesi, M., & Rubiés-Prat, J. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.121770 · Cited by 14
Skiba, P. J., Keesler, G. A., & Tabas, I. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31619-8 · Cited by 13
Using human genetics to predict the effects and side-effects of drugs
Stender, S., & Tybjærg‐Hansen, A. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000280 · Cited by 13
Groves, P. H., Rees, A., Bishop, A., Morgan, R., Ruttley, M. S. T., Lewis, N. P., Lane, I., & Hall, R. J. C. (1993) · Heart · doi:10.1136/hrt.69.1.26 · Cited by 12
Apo(a) isoforms do not predict risk for coronary heart disease in a Gulf Arab population
Akanji, A. O. (2000) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563001899285 · Cited by 12
Denti, L., Marchini, L. R., Pasolini, G., et al. (1995) · PubMed · Cited by 12
Gazzaruso, C., Garzaniti, A., Buscaglia, P., et al. (1998) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199802000-00005 · Cited by 12
Zhuang, Y. Y., Wang, J. J., & Xu, P. (1993) · PubMed · Cited by 10
Gözdaşoğlu, S., Uysal, Z., Ertem, M., et al. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00099-3 · Cited by 8
Emanuele, E., Peros, E., Minoretti, P., et al. (2004) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(04)80004-8 · Cited by 7
[Lipoprotein(a): an indicator of risk in thromboembolic disease?].
März, W., Aygören, E., Trommlitz, M., et al. (1990) · PubMed · Cited by 7
[Apolipoprotein (a) polymorphism in relation to coronary heart disease in Chinese Han nationality].
Qin, S., Wang, S., & Li, C. (1995) · PubMed · Cited by 7
Emanuele, E., Peros, E., Minoretti, P., et al. (2003) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-3-12 · Cited by 6
Apolipoprotein(a) isoforms in infarcted men under 60 years old
Calmarza, P., Cordero, J., Santos, V., & Vella, J. C. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.06.001 · Cited by 6
Bigot‐Corbel, E., Robert, B., Bard, J., & Mainard, F. (1997) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)00107-1 · Cited by 5
Spence, J. D. (2006) · Stroke · doi:10.1161/01.str.0000222979.34697.bf · Cited by 5
Correlation analysis between serum lipoprotein (a) and the incidence of aortic valve sclerosis.
Yang, N., Zhang, G., Li, X., & Zhou, L. (2015) · PubMed · Cited by 4
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Self-citationKronenberg, F., Mora, S., Stroes, E. S. G., Ference, B. A., Arsenault, B. J., Berglund, L., Dweck, M. R., Koschinsky, M., Lambert, G., Mach, F., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac361 · Cited by 1,449
Self-citation
Metadata
- Authors
- Nordestgaard, B. G., & Langsted, A.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Nordestgaard, Børge G.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 57
- Issue
- 11
- Pages
- 1953-1975
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC5087876
- OpenAlex
- W2526556731
- Cited by
- 575
- References
- 290
- Citations by year
- 2026: 46 · 2025: 66 · 2024: 72 · 2023: 65 · 2022: 72 · 2021: 59 · 2020: 67 · 2019: 60 · 2018: 37 · 2017: 28 · 2016: 2
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 1410 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- lipoprotein(a), cardiovascular disease, causal risk factors, LPA gene, Mendelian randomization, genetic association, plasminogen homology, aortic stenosis, myocardial infarction, atherosclerotic stenosis, Lp(a) screening, LDL cholesterol, reverse causality, confounding
- MeSH terms
- Aortic Valve Stenosis, Cardiovascular Diseases, Humans, Myocardial Infarction, Risk Factors, Lipoprotein(a), Genetic Predisposition to Disease, DNA Copy Number Variations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.